Xin Cheng
- Infectious Diseases top 2%
- Epidemiology top 10%
- Neurology top 5%
- Molecular Biology
- Surgery
- Topics
- COVID-19 Clinical Research Studies (6 papers)Hepatitis B Virus Studies (6 papers)SARS-CoV-2 and COVID-19 Research (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xin Cheng
38 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Infectious Diseases 627
- Epidemiology 301
- Neurology 297
- Molecular Biology 129
- Surgery 129
Countries citing papers authored by Xin Cheng
This map shows the geographic impact of Xin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Cheng more than expected).
Fields of papers citing papers by Xin Cheng
This network shows the impact of papers produced by Xin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Cheng. The network helps show where Xin Cheng may publish in the future.
Co-authorship network of co-authors of Xin Cheng
This figure shows the co-authorship network connecting the top 25 collaborators of Xin Cheng. A scholar is included among the top collaborators of Xin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Cheng. Xin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 5 | |
| 4 | 14 | |
| 5 | 19 | |
| 6 | 54 | |
| 7 | Clinical Features of COVID-19-Related Liver Functional Abnormalitybreakdown → | 619 |
| 8 | 3 | |
| 9 | 18 | |
| 10 | 10 | |
| 11 | 15 | |
| 12 | 25 | |
| 13 | 9 | |
| 14 | 27 | |
| 15 | 5 | |
| 16 | 25 | |
| 17 | 19 | |
| 18 | 3 | |
| 19 | 5 | |
| 20 | 6 |
About Xin Cheng
Xin Cheng is a scholar working on Leadership and Management, Infectious Diseases and Hepatology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Hepatitis B Virus Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (627 citations), Neurology (297 citations) and Hepatology (89 citations). Xin Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jilin Cheng, Shaoping Huang, Jingmao Yang, Zhenyu Fan, Zhanju Liu, Cheng Tian, Jun Li, Yajun Zhang, Liping Chen and Bingqing Yang. Their work appears in journals such as PLoS ONE, Biometrics and Environmental Health Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.